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Abstract
1.	 The	 immune	 system	affects	 senescence	 (declines	 in	 probabilities	of	 survival	 or	
reproduction	with	age),	by	shaping	late	age	vulnerability	to	chronic	inflammatory	
diseases	and	infections.	It	is	also	a	dynamic	interactive	system	that	must	balance	
competing	demands	across	the	life	course.	Thus,	immune	system	function	remains	
an	important	frontier	in	understanding	the	evolution	of	senescence.
2.	 Here,	we	review	our	expanding	mechanistic	understanding	of	 immune	function	
over	the	life	course,	in	the	context	of	theoretical	predictions	from	life‐history	evo-
lution.	We	are	especially	interested	in	stage‐	and	sex‐dependent	costs	and	ben-
efits	of	investment	in	the	immune	system,	given	differential	life‐history	priorities	
of	the	life	stages	and	sexes.
3.	 We	introduce	the	costs	likely	to	govern	immune	allocation	across	the	life	course.	
We	then	discuss	theoretical	expectations	for	differences	between	the	sexes	and	
their	likely	consequences	in	terms	of	how	the	immune	system	is	both	modulated	
by	and	may	modulate	senescence,	building	on	information	from	life‐history	the-
ory,	experimental	immunology	and	demography.
4.	 We	argue	that	sex	differences	 in	 immune	function	provide	a	potentially	power-
ful	probe	of	selection	pressures	on	the	immune	system	across	the	life	course.	In	
particular,	differences	in	‘competing’	and	‘caring’	between	the	sexes	have	evolved	
across	the	tree	of	life,	providing	repeated	instances	of	divergent	selection	pres-
sures	on	immune	function	occurring	within	the	same	overall	bauplan.
5.	 We	conclude	by	detailing	an	agenda	for	future	research,	including	development	
of	theoretical	predictions	of	the	differences	between	the	sexes	under	an	array	of	
existing	models	for	sex	differences	in	immunity,	and	empirical	tests	of	such	pre-
dictions	across	the	tree	of	life.
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1  | INTRODUC TION
The	 twin	 mysteries	 of	 how	 and	 why	 sex	 differences	 and	 senes-
cence	(declines	in	probabilities	of	survival	or	reproduction	with	age)	
evolved	have	long	fascinated	evolutionary	biologists.	Here,	we	pro-
pose	that	sex‐	and	age‐dependent	variation	in	immune	function	pro-
vide	complementary	insights	into	these	mysteries.	First,	we	outline	
the	theory	underpinning	the	evolution	of	senescence,	 followed	by	
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an	overview	of	late	age	immune	responses.	We	then	discuss	immune	
trade‐offs	 and	 outline	 how	 they	 may	 connect	 early	 and	 late	 life	
survival	or	 fertility,	a	key	question	 in	the	evolution	of	senescence.	
Finally,	we	place	this	in	the	context	of	theoretical	expectations	for	
sex	differences	in	immunity,	concluding	with	future	directions	that	
could	 leverage	 sex	 differences	 to	 illuminate	 links	 between	 senes-
cence	and	immunity.
2  | THE THEORETIC AL CONTE X T
Why	 do	 we	 ‘age’?	 Fisher	 argued	 that	 senescence	 emerges	 as	 a	
result	 of	 the	 accumulation	of	deleterious	 age‐specific	 traits	 that	
cannot	be	efficiently	removed	by	natural	selection	(Fisher,	1930).	
Such	 ‘mutation accumulation’	 will	 lead	 to	 senescence,	 as	 further	
formalized	by	Haldane	 (Haldane,	1942)	 and	Medawar	 (Medawar,	
1952).	 By	 1957,	 Williams	 introduced	 the	 concept	 of	 ‘antagonis‐
tic pleiotropy’	where	 a	mutation	 that	 increased	 survival	 or	 fertil-
ity	early	 in	 life	 at	 the	expense	of	 survival	or	 fertility	 later	 in	 life	
would	 be	 likely	 to	 spread	 in	 a	 population.	Williams	 also	 laid	 out	
theoretical	 expectations	 for	 differences	 in	 senescence	 between	
the	sexes	(Williams,	1957),	predicting	that	the	sex	with	‘the	higher	
[background]	 mortality	 rate,	 and	 the	 lesser	 rate	 of	 increase	 in	
fecundity’	 with	 age	 should	 undergo	 the	most	 rapid	 senescence,	
for	example	the	more	rapid	increase	in	mortality	with	age.	While	
higher	rates	of	actuarial	senescence	are	observed	in	males	in	some	
mammal	 species	 for	which	males	 have	higher	mortality	 (Gaillard	
&	 Lemaître,	 2017),	 exceptions	 can	 also	 be	 found	 (e.g.	 large	 her-
bivores	(Lemaître	&	Gaillard,	2013)).	Theory	indicates	that	higher	
background	mortality	alone	(within	a	sex,	or	a	species)	should	not	
modulate	evolution	of	changes	 in	mortality	 (or	 fertility)	over	age	
(Caswell,	2007;	Moorad,	Promislow,	&	Silvertown,	2019;	Wensink,	
Caswell,	&	Baudisch,	2017),	so	that	other	features	of	the	life	his-
tory	are	likely	to	drive	this	empirical	pattern	(Abrams,	1993).	For	
sex	differences,	trade‐offs	underlying	differences	in	mortality	and	
fertility	between	the	sexes	will	be	key.
Male–female	comparisons	have	long	been	recognized	as	a	useful	
axis	for	considering	how	selection	shapes	longevity	and	senescence	
(Williams,	1957).	Williams	noted	that	two	interacting	proximate fea-
tures	shape	sex	differences:	the	chromosome	differences	between	
the	sexes	set	at	conception	and	hormonal	differences	that	develop	
over	ontogeny,	which	will	 intersect	 to	define	differences	between	
male	and	 female	phenotypes.	He	 further	posited	 that	 the	ultimate 
drivers	of	 sex	differences	 in	 longevity	 and	 senescence	will	 be	dif-
ferences	in	schedules	of	mortality	and	fertility	(Williams,	1957),	and	
associated	trade‐offs,	in	turn	rooted	in	differential	investment	in	pa-
rental	care	(Keller,	Bayer,	Salzburger,	&	Roth,	2018;	Roth,	Scharsack,	
Keller,	 &	 Reusch,	 2011)	 or	 towards	 sexual	 competition	 (Clutton‐
Brock	&	Isvaran,	2007).
What	does	this	theory	mean	for	selection	on	immune	function	
(i.e.	 the	 various	 roles	 of	 immune	 systems	 in	 organismal	 physiol-
ogy,	 including	defence	 against	 infection)	 across	 the	 sexes?	Early	
experimental	work	(Bateman,	1948)	yielded	one	simple	prediction:	
the	 sex	 that	obtained	 the	greatest	 fitness	 returns	 from	securing	
matings	 (sexual	 selection)	 should	 favour	 investment	 away	 from	
survival	and	towards	competition.	Due	to	survival	benefits	of	de-
fence	 against	 infection,	 despite	 predicted	 resource	 costs	 of	 im-
mune	 responses,	 it	 was	 subsequently	 suggested	 that	 this	 might	
be	via	 reduced	 investment	 in	 immune	 function	 (e.g.	Rolff,	2002;	
Sheldon	&	Verhulst,	1996).	In	this	framework,	the	sex	under	stron-
ger	sexual	selection	and	thus	with	higher	variance	in	reproductive	
success	(often	males)	was	predicted	to	have	weaker	immune	func-
tion.	This	may	be	an	excellent	first	approximation	(Zuk,	2009),	with	
predictive	 power	 in	 a	 range	 of	 settings,	 but	 theoretical	 probing	
shows	that	it	also	hinges	on	strong	assumptions	(Stoehr	&	Kokko,	
2006).	In	particular,	the	links	from	immune	responses	to	survival,	
and	indeed	survival	to	female	fitness,	need	not	be	straightforward	
(Forbes,	 2007).	 Furthermore,	 contrasting	 ‘strong’	 versus	 ‘weak’	
immune	responses	of	the	two	sexes	obscures	the	fact	that	selec-
tion	might	differentially	affect	various	aspects	of	immune	function	
(Stoehr	&	Kokko,	 2006),	 from	pathogen	detection	 to	 the	magni-
tude	 of	 a	 pathogen‐killing	 response	 (Metcalf	 &	 Graham,	 2018;	
Metcalf,	Tate,	&	Graham,	2017).
Understanding	 the	 role	 of	 immune	 function	 in	 senescence	
is	 also	 challenging,	 because	 the	 immune	 system	 is	 a	master	 regu-
lator	of	physiology	and	homeostasis,	and	plays	varied	 roles	across	
age	 (Figure	1).	Efforts	 to	 identify	 reliable	biomarkers	of	ageing	 in-
creasingly	encompass	measures	of	immune	function	(Nussey,	Watt,	
Pilkington,	 Zamoyska,	&	McNeilly,	 2011).	 Yet,	 the	 diversity	 of	 im-
mune	 cells,	 and	 how	 they	 affect	 each	 other's	 activity	 (Figure	 2),	
makes	 interpreting	 such	measures	 challenging.	 One	 path	 forward	
is	 to	 leverage	 clear	 contrasts:	 striking	 sex	 differences	 in	 immune	
function	 (Klein	 &	 Flanagan,	 2016),	 for	 which	 we	 have	 a	 growing	
mechanistic	understanding	(Box	1),	provide	a	foundation	for	probing	
how	(proximately)	and	why	(ultimately)	the	immune	system	affects	
senescence.
3  | AGEING AND IMMUNE FUNC TION
Late	age	 (dys)function	 is	shaped	by	mutation	accumulation	 (where	
rarity	 of	 late	 age	 individuals	 allows	 fixation	 of	 deleterious	 muta-
tions)	 or	 trade‐offs	 playing	 out	 across	 age	 (whether	 genetic,	 as	 in	
antagonistic	 pleiotropy,	 or	 physiological,	 phenotypically	 plastic,	 as	
in	allocation	of	limited	resources	between	physiological	functions).	
While	pinpointing	specific	mechanisms	is	challenging	(e.g.	mutation	
accumulation	requires	demonstrating	that	alleles	only	have	deleteri-
ous	 effects,	which	 only	manifest	 at	 later	 ages),	 function	 is	 always	
predicted	 to	 decline	with	 age.	 Immune	 function	 displays	 patterns	
that	align	with	this	prediction,	but	also	ones	that	(initially)	seem	at	
odds	with	it.
Many	innate	effectors	do	decline	with	age,	for	example	in	phago-
cytic	ability,	 intracellular	killing	or	chemotactic	 response	 (Boraschi	
et	al.,	2013;	Simon,	Hollander,	&	McMichael,	2015;	Uciechowski	&	
Rink,	 2018).	Adaptive	 immune	 cells	 also	 show	declines:	 for	 exam-
ple,	 individual	 B	 lymphocytes	 accumulate	 somatic	mutations	 over	
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age	that	impair	repair	(Zhang	et	al.,	2019),	 just	as	the	ability	of	the	
whole	 B‐cell	 population	 to	 generate	 novel	 response	 declines	 (de	
Bourcy	et	al.,	2017).	However,	phenotypes	suggestive	of	higher	im-
mune	function	at	late	ages	are	also	reported,	for	example	with	higher	
expression	of	innate	immune	genes	(Landis	et	al.,	2004),	or	antimi-
crobial	peptides	(Zerofsky,	Harel,	Silverman,	&	Tatar,	2005)	 in	fruit	
flies.	Nonetheless,	high	baseline	activation	coincides	with	a	reduced	
ability	to	induce	responses	upon	infection	(Zerofsky	et	al.,	2005)	and	
has	also	been	associated	with	reduced	longevity	(Fabian	et	al.,	2018).	
For	adaptive	immunity,	antibody	titres	(e.g.	for	influenza	(Lessler	et	
al.,	2012))	can	also	be	higher	with	age	in	humans	but	it	is	not	clear	
that	this	translates	into	greater	protection	from	infection.	These	ex-
amples	 illustrate	 the	 important	point	 that	greater	abundance	does	
not	necessarily	translate	into	greater	functionality	for	immune	effec-
tors.	Beyond	abundance,	the	trade‐offs	that	shape	immune	function	
and	 the	dynamic	 interactions	of	 relevant	 cell	 populations	must	be	
considered.
4  | TR ADE‐ OFFS A SSOCIATED WITH 
IMMUNE FUNC TION OVER THE LIFE 
COURSE
Hosts	are	prevented	from	achieving	perfect	immune	defence	against	
all	 threats	by	trade‐offs	 that	emerge	from	allocation	of	 limited	re-
sources	between	different	necessary	life‐history	functions	(Sheldon	
&	 Verhulst,	 1996)—for	 example,	 investment	 towards	 immune	 re-
sponses	 might	 reduce	 resources	 available	 for	 other	 life‐history	
priorities	such	as	growth	or	fertility.	Compounding	the	problem,	pro-
tection	against	pathogens	often	comes	at	the	cost	of	‘self‐harm’	due	
to	 collateral	 damage	 associated	with	 powerful	 immune	 responses	
(Graham,	Allen,	&	Read,	2005;	Sorci,	Lippens,	Léchenault,	&	Faivre,	
2017).	Evolution	will	select	hosts	to	compromise	between	compet-
ing	needs	across	the	life	cycle	(McKean	&	Lazzaro,	2011).	To	this	end,	
the	optimal	immune	response	is	rarely	maximal	(Cressler,	Graham,	&	
Day,	2015).
At	the	most	basic	scale,	selection	may	determine	whether	hosts	
do,	or	do	not,	invest	in	immune	defence	(Rolff	&	Siva‐Jothy,	2003).	
For	example,	Drosophila	constitutively	able	to	defend	against	patho-
gens	show	lower	larval	ability	to	acquire	food	(Kraaijeveld,	Limentani,	
&	Godfray,	 2001).	Maintaining	 constitutive	 or	 fixed	defences	may	
be	costly.	For	example,	 resistance	to	bacterial	 infection	negatively	
correlates	with	fecundity	of	uninfected	fruit	flies	(McKean,	Yourth,	
Lazzaro,	 &	Clark,	 2008).	 Such	maintenance	 costs	might	 select	 for	
varied	persistence	of	immune	function	across	age.	Early	atrophy	of	
the	 thymus,	 the	 organ	where	T	 cells	 are	 produced	 in	 vertebrates,	
is	a	striking	example	of	altered	functioning	with	age	thought	to	be	
associated	with	 the	 spectacular	metabolic	 costs	of	 random	gener-
ation	of	T‐cell	 receptors	 (Palmer,	2013;	Yates,	2014).	Early	 thymus	
atrophy	could	free	up	resources	for	other	functions	(perhaps	partic-
ularly	 reproduction,	since	 involution	precedes	the	age	at	maturity)	
while	 the	 longevity	of	naive	T	cells	 and	 their	 capacity	 for	homeo-
static	proliferation	preserve	function	temporarily.	Sex	differences	in	
rates	of	thymus	atrophy	provide	one	interesting	line	of	investigation	
into	immune	function	effects	on	senescence	(Pido‐Lopez,	Imami,	&	
Aspinall,	2001).
Beyond	the	relative	benefits	of	 ‘having’	and	 ‘maintaining’	an	 im-
mune	 system,	 costs	 of	 ‘using’	 an	 immune	 system	 have	 presumably	
been	central	in	shaping	the	ubiquity	of	inducibility	and	active	down-
regulation	across	 the	 life	cycle	 (McKean	&	Lazzaro,	2011).	 Infection	
or	 other	 immune	 ‘insults’	 occur	 repeatedly	 through	 life	 (Figure	 1,	
F I G U R E  1  Mortality	and	immunity	across	the	life	course.	(a)	
Mortality	rates	(y‐axis)	tend	to	decline	during	the	first	years	of	
life	(x‐axis	is	age)	as	individuals	grow	out	of	small	vulnerable	life	
stages	and	then	increase	later	in	life,	a	manifestation	of	senescence	
or	ageing	(noting	that	a	wide	range	of	mortality	trajectories	are	
possible).	Mortality	rates	are	often	higher	in	one	sex	across	all	ages	
(e.g.	red	vs.	blue).	On	top	of	this,	sex	differences	in	senescence	and	
thus	longevity	might	manifest	via	an	increase	in	the	rate	of	ageing	
(blue	dashed	line)	or	an	earlier	age	of	onset	of	ageing	(blue	dotted	
line)	in	one	or	other	sex.	One	sex	might	also	have	higher	mortality	
associated	with	reproductive	years	(shown	as	the	horizontal	red	
line	above	the	baseline).	(b)	Differences	in	age	trajectories	of	
mortality	will	translate	into	different	age	profiles	(red	vs.	blue	
bars,	here	assuming	equal	sex	ratios	at	birth),	but	older	individuals	
are	consistently	rare,	an	important	driver	of	the	evolution	of	
senescence	(noting,	however,	that	late	age	individuals	might	have	
high	reproductive	value	that	could	counterweight	this	effect).	
(c)	The	immune	system	is	involved	in	both	protection	(infectious	
diseases	and	cancers)	and	harmful	outcomes	(immunopathologies,	
such	as	cardiovascular	disease,	strokes	or	autoimmunity)	across	this	
same	time	course	(x‐axis	indicates	age,	with	for	example	cancers	
predominantly	arising	at	late	ages)
4  |    Functional Ecology METCALF ET AL.
Figure	2).	If	an	immune	response	is	induced,	costs	can	escalate	rapidly	
as	a	result	of	positive	feedback	in	the	immune	signalling	system	(‘cyto-
kine	storms’)	but	equally	are	subject	to	negative	feedback	loops	that	
can	swiftly	shut	the	process	down	(Frank,	2002).	These	positive	and	
negative	feedback	dynamics	are	also	associated	with	legacy	effects	of	
potentially	great	significance	 in	considering	how	selection	plays	out	
across	age.	For	example,	because	T	cells	play	a	key	role	in	immune	reg-
ulation	(Figure	2),	when	the	thymus	atrophies	and	T	cells	reach	their	
Hayflick	 limit	 (Ndifon	&	Dushoff,	 2016)	 induced	 immune	 responses	
may	 spiral	 out	of	 control.	 In	 particular,	 the	moderating	 influence	of	
regulatory	T	cells	upon	other	 cells	 (Moore,	Waal	Malefyt,	Coffman,	
&	O'Garra,	 2001)	will	wane	 as	 they	decline.	 The	density	 and	 activ-
ity	of	killer	and	innate	cells	may	then	increase,	alongside	increases	in	
pro‐inflammatory	molecules	(Okin	&	Medzhitov,	2012).	The	tipping	of	
the	balance	away	from	regulation	towards	inflammation	is	potentially	
exacerbated	by	declines	in	the	efficacy	of	autophagy,	or	clearance	of	
cellular	 detritus	 (Rea	 et	 al.,	 2018),	 and	 drives	 chronic	 inflammation	
in	older	individuals	(Okin	&	Medzhitov,	2012).	This	syndrome	is	also	
referred	 to	 as	 ‘inflammaging’	 (Franceschi	 et	 al.,	 2000)	 and	 confers	
greater	 risk	 of	mortality	 associated	with	 immunopathology.	 Indeed,	
adaptive	immune	components	senesce	faster	on	average	than	innate	
components	in	wild	animals	(Peters,	Delhey,	Nakagawa,	Aulsebrook,	
&	Verhulst,	 2019),	 though	 disregulation	 of	 innate	 immunity	 is	 likely	
what	kills	hosts	 (Okin	&	Medzhitov,	2012).	Latent	or	chronic	patho-
gens	may	play	a	role—cytomegalovirus	has	been	identified	as	uniquely	
important	for	 immunosenescence	(Pawelec,	2014)	as	 it	monopolizes	
and	exhausts	T	cells	(Schober,	Buchholz,	&	Busch,	2018).	Such	late	age	
dysregulation	of	 immunity	 is	evidenced	 in	 invertebrate	 systems	 too	
(Fabian	et	al.,	2018;	Khan,	Agashe,	&	Rolff,	2017).	Furthermore,	 im-
mune	pathways	have	been	shown	to	differ	between	the	sexes	(Fabian	
et	al.,	2018)	RNAi	silencing	of	transcription	factors	increases	male	lon-
gevity	and	reduces	female	longevity.	In	general,	however,	sex	differ-
ences	in	onset	or	rate	of	inflammaging	remain	understudied.
We	can	translate	the	strategic	decisions	involved	around	induc-
tion	of	an	immune	response	(Figure	2)	into	life‐history	terms,	focus-
ing	 first	on	 survival.	 First,	 induction	 is	 associated	with	a	 trade‐off	
based	around	discriminating	whether	or	not	to	respond	(Metcalf	et	
al.,	2017).	The	cost	of	false	negatives	 (failing	to	detect	a	pathogen	
that	 is	 present)	must	 be	 balanced	with	 the	 cost	 of	 false	 positives	
(launching	an	immune	response	in	the	absence	of	a	threat	could	re-
sult	 solely	 in	 costly	 immunopathology,	 Figure	 3a).	 Since	 the	 costs	
of	immunopathology	(false	positives,	Figure	3a)	will	manifest	in	the	
F I G U R E  2  Dynamics	of	immunity.	Many	immune	defences	are	inducible,	triggered	once	growing	parasite	populations	(red	hexagons)	
are	detected	by	the	pattern	recognition	receptors	of	innate	immunity	identifying	either	pathogen‐ or damage‐associated	molecular	
patterns	(x‐axis	is	time	following	parasite	arrival).	Innate	immune	effectors	are	then	launched	(purple	lightning	bars).	For	species	that	have	
adaptive	immunity,	lymphocytes	can	subsequently	be	recruited	(coloured	circles),	potentially	leading	to	amplification	of	specific	B‐	or	T‐cell	
clones	that	recognize	the	pathogen	(blue	circles).	These	early	processes	generally	correspond	to	a	phase	of	positive	feedback.	Immune	
defences	are	also	associated	with	active	downregulation,	by	production	of	repressive	cytokines,	such	as	IL10,	or	(for	species	with	adaptive	
immunity)	engagement	of	T‐regs	promoting	a	tolerizing	environment,	that	is	a	phase	of	negative	feedback.	Infection	and	the	broad	return	
to	homeostasis	may	nevertheless	harbour	changes	that	can	result	in	longer	term	effects	(far	right)	that	may	negatively	(purple)	or	positively	
(green)	affect	survival	rates.	Background	damage	shaped	by	immune	effectors	could	potentially	driving	earlier	or	faster	senescence;	
‘learning’	by	immunity	will	both	enhance	protection	to	previously	observed	pathogens,	but	deplete	memory,	reducing	ability	to	‘remember’	
new	pathogens.	Finally,	early	infection	may	enable	immunity	to	develop	a	broadly	tolerizing	environment,	protecting	the	organism	from	late	
life	immunopathology.	Each	of	these	phases	of	induction	and	return	to	homeostasis	map	onto	different	trade‐offs	relevant	for	balancing	
costs	associated	with	immunity	(alphabetically	labelled	boxes	correspond	to	labels	on	Figure	3).	The	whole	process	can	potentially	occur	
multiple	times	over	the	course	of	an	individual's	life	span,	with	potential	consequences	for	rates	of	senescence	(see	text)
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BOX 1 Proximate determinants of sex differences and immunity
There	are	two	proximate	determinants	of	sex	differences:	chromosomes	and	hormones.	Although	not	universal,	chromosomal	sex	de-
termination	is	widespread.	Diverse	mechanisms	have	evolved	to	prevent	double	dosage	of	proteins	in	the	homozygous	sex	relative	to	
the	heterozygous	sex	(‘dosage	compensation’).	In	mammalian	females,	one	X	chromosome	in	each	cell	is	inactivated:	about	half	the	cells	
express	genes	derived	from	the	maternal	X	chromosome,	and	half	express	genes	from	the	paternal	X	chromosome.	Female	mammals	
thus	have	striking	physiological	immune	diversity	relative	to	males,	potentially	amplifying	their	ability	to	survive	the	onslaught	of	diverse	
pathogens	(Marais	et	al.,	2018).	Additionally,	immune	genes	are	highly	enriched	on	the	X	chromosome	(Libert,	Dejager,	&	Pinheiro,	2010),	
which	may	further	amplify	this	effect.	For	example,	in	humans,	two	key	pattern	recognition	receptors	are	encoded	on	the	X,	toll‐like	
receptors	7	and	8	(Jaillon,	Berthenet,	&	Garlanda,	2019),	and	in	Drosophila,	the	X	chromosome	encodes	an	array	of	immune	genes,	in-
cluding	peptidoglycan‐recognition	protein	(Hill‐Burns	&	Clark,	2009).
Across	tetrapods,	individuals	of	the	hemizygous	sex	(e.g.	XY	in	mammals,	or	ZW	in	birds,	and	a	variety	of	patterns	among	reptiles	and	
amphibians)	have	lower	survival	to	adulthood	(Pipoly	et	al.,	2015).	This	has	been	attributed	to	mechanisms	including	the	‘unguarded	
chromosome’	effect,	where	expression	of	recessive	mutations	 in	the	hemizygous	sex	reduces	survival	 (Maklakov	&	Lummaa,	2013);	
the	‘toxic	chromosome’	effect,	where	control	of	transposable	elements	on	the	hemizygous	chromosome	is	lost	at	late	ages;	and	finally,	
hemizygous	‘chromosome	loss’,	a	phenomenon	that	can	occur	across	multiple	cell	cycles	(Marais	et	al.,	2018).	The	role	played	by	immu-
nity	is	hard	to	titrate,	as	how	immune	genes	cluster	across	sex	chromosomes	remains	poorly	specified	across	vertebrates,	but	patterns	
similar	to	those	observed	in	well‐described	organisms	(humans,	Drosophila)	might	contribute	to	vulnerability	of	the	hemizygous	sex.	
The	dangerous	side	of	immunity	also	means	that	the	sex	associated	with	a	concentration	of	immune	genes	may	be	at	risk	in	other	ways:	
for	example,	biased	dosage	compensation	has	been	implicated	in	autoimmunity,	as	a	result	of	escape	from	inactivation	of	specific	innate	
immune	genes	found	on	the	X	(Souyris	et	al.,	2018).
Many	species	do	not	have	chromosomal	sex	differences.	However,	all	species	with	two	sexes	feature	hormonal	differences	expressed	
at	maturity.	Almost	every	immune	cell	has	hormonal	receptors,	and	there	is	widespread	evidence	for	hormonal	effects	on	immunity	
across	the	tree	of	life	(Foo,	Nakagawa,	Rhodes,	&	Simmons,	2017).	In	vertebrates,	testosterone,	which	is	known	to	stimulate	expres-
sion	of	secondary	sexual	signals	while	potentially	suppressing	immune	defence,	has	long	been	the	main	proximate	candidate	to	explain	
decreased	immune	defence	in	males	(Folstad	&	Karter,	1992;	Foo	et	al.,	2017).	While	animal	models	indicate	that	androgens	can	reduce	
aspects	such	as	toll‐like	receptor	4	expression	on	macrophages	or	natural	killer	cell	activity	(Klein	&	Flanagan,	2016),	support	for	the	
immunosuppressive	effect	of	testosterone	is	inconsistent	(Owen‐Ashley,	Hasselquist,	&	Wingfield,	2004;	Roberts,	Buchanan,	&	Evans,	
2004).	Furthermore,	invertebrates	can	display	sexual	immune	dimorphism	yet	lack	testosterone,	indicating	that	testosterone	cannot	be	
the	whole	story	(Kurtz	&	Sauer,	2001;	McKean	&	Nunney,	2001;	Peters,	2000;	Sheridan,	Poulin,	Ward,	&	Zuk,	2000).
Female	hormonal	 levels	 (estradiol,	progesterone)	are	often	dynamic	and	generally	change	radically	during	reproductive	periods	 (e.g.	
pregnancy).	These	changes	affect	immune	functioning,	including	both	innate	and	adaptive	immunity	(Klein	&	Flanagan,	2016).	In	ver-
tebrates,	estradiol	and	progesterone	receptors	are	expressed	in	lymphocytes,	macrophages,	dendritic	cells,	etc.	Progesterone	is	gen-
erally	anti‐inflammatory,	while	estradiol	can	have	different	effects	depending	on	 its	concentration.	Low	concentrations	of	estradiol	
(e.g.	during	the	follicular	stage	of	the	reproductive	cycle)	can	be	pro‐inflammatory,	whereas	high	concentrations	(e.g.	during	the	luteal	
phase	of	the	reproductive	cycle	or	during	pregnancy)	can	be	anti‐inflammatory	(Klein	&	Flanagan,	2016).	Indeed,	inflammation	is	drasti-
cally	reduced	during	pregnancy,	largely	via	the	effects	of	hormones	(Robinson	&	Klein,	2012),	although	immunity	during	pregnancy	is	
increasingly	recognized	to	be	an	intricately	coordinated	process	rather	than	a	simple	case	of	immune	suppression	(Mor,	Aldo,	&	Alvero,	
2017).	Since	hormone	levels	change	with	age,	these	also	contribute	to	changes	in	immune	function	over	age	and	its	sex	differences.	For	
example,	in	humans,	the	innate	immune	system	of	aged	females	may	be	more	inflammation‐prone;	yet,	ageing	of	the	adaptive	immune	
system	may	occur	at	a	faster	rate	in	men	(Bupp,	Melanie,	Potluri,	Fink,	&	Klein,	2018),	presumably	as	a	result	of	how	chromosomal	and	
hormonal	differences	affect	these	different	branches	of	immunity.
Systems	that	have	evolved	along	gradients	of	parental	investment	beyond	predominantly	female	care	provide	an	intriguing	avenue	for	
probing	the	effects	of	hormones	on	immune	function,	particularly	during	pregnancy.	For	example,	syngnathids	(pipefish)	encompass	a	
spectrum	including,	uniquely	among	vertebrates,	male	pregnancy.	In	this	system,	the	sex	investing	more	into	parental	care	has	a	more	
efficient	immune	response	(Lin,	Zhang,	Liu,	&	Xiao,	2016;	Roth	et	al.,	2011),	and	during	male	pregnancy,	male	androgens	are	downregu-
lated,	whereas	glucocorticoids	and	prolactin,	typically	limited	to	vertebrate	females,	are	upregulated	(Scobell	&	Mackenzie,	2011).	Birds	
with	varying	extents	of	paternal	investment	(Eens	&	Pinxten,	2000)	show	similar	patterns.	Disentangling	the	mechanistic	basis	of	sex	
differences	in	immunity	and	linking	this	to	ultimate	drivers	will	benefit	from	such	broader	perspectives.
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absence	of	any	of	 the	hazards	 immunity	 is	designed	to	counteract	
(infection,	 cancer),	 optimizing	 around	 this	 discrimination	 trade‐off	
will	depend	on	the	pattern	of	hazard	over	age.	Where	infection	is	a	
key	hazard,	selection	could	result	in	lower	probability	of	responding	
to	infection	in	long‐lived	organisms	if	most	infection	occurs	early	in	
life	(Metcalf	&	Graham,	2018;	Metcalf	et	al.,	2017),	since	they	would	
otherwise	 pay	 the	 cost	 of	 false	 positives	 for	 longer;	 or	 declining	
probability	of	responding	over	age	if	induction	probability	is	tunable	
(Metcalf	 et	 al.,	 2017).	 This	 logic	 suggests	 that	 reduced	expression	
or	 signalling	of	many	 innate	 immune	 receptors	 at	 late	 ages	 (Shaw,	
Goldstein,	&	Montgomery,	2013)	could	actually	be	adaptive	rather	
than	 a	 manifestation	 of	 senescence.	 Sex	 differences	 in	 receptor	
expression	(Jaillon	et	al.,	2019)	again	provide	a	useful	direction	for	
investigation.
Second,	once	an	 immune	response	has	been	triggered,	the	op-
timal	magnitude	of	the	response	will	again	be	contingent:	the	ben-
efits	 of	 pathogen	 control	 must	 be	 balanced	 against	 the	 costs	 of	
self‐harm	(Figure	3b).	The	magnitude	of	the	response	(e.g.	number	
of	 immune	 effectors	 launched)	must	 be	 large	 enough	 to	 diminish	
pathogen‐associated	 mortality	 yet	 not	 sufficiently	 large	 as	 to	 re-
sult	 in	 excessive	 immunopathology.	Optimizing	 around	 this	 trade‐
off	 will	 depend	 on	 where	 organisms	 lie	 along	 the	 discrimination	
F I G U R E  3   Immune	trade‐offs.	(a)	A	discrimination	trade‐off:	distinguishing	between	overlapping	molecular	signatures	of	the	host	(grey	
histogram)	and	pathogens	(black	histogram),	or	deciding	where	to	draw	the	dashed	vertical	line,	results	in	a	trade‐off	between	false	positive	
and	false	negatives	(this	is	framed	as	a	sensitivity/specificity	trade‐off	by	epidemiologists,	lower	panel).	(b)	A	trade‐off	around	the	magnitude	
of	the	immune	response:	large	responses	(x‐axis,	response	magnitude	increases	left	to	right)	reduce	parasite	burden	(top	panel,	black	line)	and	
thus	reduce	the	impact	of	parasites	on	mortality	(lower	panel,	the	black	bars	reflecting	how	parasites	reduce	host	survival	diminish	in	size)	but	
increase	negative	effects	associated	with	immunopathology	(lower	panel,	purple	bars	reflecting	how	immunopathology	reduces	host	survival	
increase	in	size).	The	optimal	response	is	where	the	combined	burden	of	parasite‐associated	mortality	and	immunopathology‐related	mortality	
is	the	smallest	(vertical	dashed	black	line).	Relative	to	this	baseline,	hosts	might	be	(c)	more	tolerant,	where	the	trajectory	of	parasite	burden	(top	
panel)	is	unchanged	but	the	impact	of	parasites	on	survival	is	reduced	(black	bars	are	smaller,	noting	that	impacts	might	manifest	via	fertility	
instead),	or	(d)	more	resistant,	where	the	parasite	burden	is	lower	for	equivalent	magnitude	immune	responses.	The	base	case	(b)	represents	the	
trade‐off	directly	emerging	from	danger	associated	with	immunity,	but	both	tolerance	and	resistance	will	require	additional	resource	allocation,	
and	are	thus	often	found	to	trade‐off.	Tracing	these	four	trade‐offs	across	the	life	span	is	an	important	direction	for	future	work
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trade‐off—higher	 sensitivity	 (more	 false	 positives)	will	 entail	more	
frequent	 responses,	 and	 can	 thus	 select	 for	 lower	 magnitude	 re-
sponses	(Metcalf	&	Graham,	2018),	which	might	also	vary	between	
the	sexes.	Figure	3b	focusses	on	survival,	but	the	cost	could	also	be	
to	 fertility—for	example	 fallopian	 tube	scarring	caused	by	 immune	
responses	to	Chlamydia trachomatis	infection	reduces	female	fertility	
(Johnson,	Kerr,	&	Slaven,	2014)	suggesting	differences	in	trade‐off	
structure	between	the	sexes.
In	some	contexts,	the	magnitude	of	 induced	responses	also	 in-
tersects	with	 another	 set	 of	 trade‐offs	 (e.g.	 Raberg,	 Sim,	&	 Read,	
2007).	For	example,	selection	may	favour	the	evolution	of	‘tolerance’	
strategies,	 via	 which	 tolerant	 hosts	 suffer	 considerably	 lower	 fit-
ness	impacts	than	intolerant	hosts	at	equivalent	pathogen	burdens	
(Figure	3c),	and/or	‘resistance’	strategies	(Figure	3d)	via	which	hosts	
minimize	fitness	impacts	of	infection	by	reducing	pathogen	burden.	
In	systems	such	as	rodent	malaria,	there	is	a	trade‐off	between	re-
sistance	and	tolerance	(Raberg	et	al.,	2007);	however,	the	trade‐off	
between	the	strategies	is	not	universal.	As	for	optimal	discrimination	
(above),	the	optimal	strategy	might	depend	on	timing	during	the	life	
course:	 for	 example	 a	 transition	 from	 ‘resistance’	 to	 ‘tolerance’	 as	
animal	age	has	been	suggested	in	rodents	(Jackson	et	al.,	2014)	and	
sheep	(Froy	et	al.,	2019;	Garnier	et	al.,	2017).
5  | INTER AC TIONS BET WEEN IMMUNE 
FUNC TION E ARLY AND L ATE IN LIFE
Natural	 selection	 should	 optimize	 across	 immune	 trade‐offs	
(Figure	3)	in	the	context	of	life	history—with	strategies	likely	to	be	
highly	plastic	along	the	life	course	(Love,	Salvante,	Dale,	&	Williams,	
2008).	Optimization	should	also	increase	early	life	survival	and	fertil-
ity	at	the	expense	of	later	life	survival	and	fertility	(Williams,	1957).	
This	prediction	aligns	with	evidence	that	damage	associated	with	im-
munopathology	resulting	from	early	infection	may	have	long‐lasting	
negative	 effects	 (Figure	2),	with	 reduced	 longevity	 of	 bacteria‐re-
sistant	flour	beetles	relative	to	RNAi	knockouts	of	a	key	immune	ef-
fector	(Khan	et	al.,	2017).	However,	such	patterns	are	not	ubiquitous,	
with	no	effect	of	 early	 inflammation	on	 longevity	or	 reproductive	
output	in	murine	malaria	(Lippens	et	al.,	2019)	despite	evidence	that	
aged	mice	are	more	likely	to	die	of	inflammation	(Belloni	et	al.,	2010).
Indeed,	the	dynamic	nature	of	immune	function	means	that	the	
opposite	can	also	occur,	that	 is	 increased	early	 life	hazards	associ-
ated	with	protection	later	in	life	(Figure	2).	For	example,	data	from	
human	populations	 suggest	 that	early	 infection	may	be	protective	
as	 it	 allows	 the	 immune	 system	 to	 learn	 to	 ‘curb’	 itself	 (McDade,	
2012).	 Another	 phenomenon	 that	 can	 result	 in	 this	 pattern	 is	 im-
mune	memory.	Exposure	to	a	pathogen	can	result	in	subsequent	pro-
tection	from	that	same	pathogen,	via	lymphocyte‐mediated	memory	
in	 vertebrates,	 or	 analogues	 (thus	 far	 largely	 described	 phenome-
nologically	 rather	 than	mechanistically)	 in	 invertebrates	 (Pinaud	et	
al.,	2016;	Watson	et	al.,	2005).	 If	 ‘remembered’	 responses	provide	
an	important	 line	of	 immune	defence,	then,	 in	contrast	to	theoret-
ical	predictions,	early	life	cannot	be	protected	over	and	above	late	
life	(setting	effects	due	to	transgenerational	immune	priming	to	the	
side).	 For	 example,	 pathogens	 like	measles	 contribute	 little	 to	 late	
age	mortality,	because	most	individuals	are	infected	early	in	life,	thus	
acquiring	 complete	 immune	 protection	 for	 the	 rest	 of	 their	 lives.	
How	much	this	contributes	to	emergent	late	age	mortality	will	de-
pend	on	the	relative	risk	of	encountering	novel	versus	previously	ex-
perienced	pathogens.	Since	immune	memory	relies	on	selection	for	
clonal	amplification	(in	vertebrates),	particular	T	cells	can	dominate	
memory	 (Qi	et	al.,	2014)	potentially	beyond	what	would	be	useful	
in	 defence,	 and	 in	 the	worst	 case,	 strongly	 targeting	 self‐antigens	
(Deshpande,	 Parrish,	 and	 Kuhns,	 2015).	 Both	memory	 imbalances	
and	autoimmune	disease	could	reduce	survival	at	later	ages.
6  | ULTIMATE DETERMINANTS OF 
SE X DIFFERENCES IN IMMUNIT Y: 
IMPLIC ATIONS FOR SENESCENCE
To	 probe	 how	 the	 dynamic	 (Figure	 2)	 interacting	 trade‐offs	
(Figure	 3)	 associated	with	 immune	 function	 translate	 into	 senes-
cence,	we	next	 focus	on	how	strikingly	diverse	sex	differences	 in	
immunity	 (Klein	&	 Flanagan,	 2016)	might	 evolve,	 and	 infer	 impli-
cations	 for	 the	evolution	of	 senescence.	While	 the	proximate	de-
terminants	of	 sex	differences	 can	 include	both	 chromosomal	 and	
hormonal	differences	(Box	1),	ultimate	determinants	will	be	rooted	
in	 differences	 in	 investments	 in	 competing	 and	 caring	 between	
males	and	 females	given	core	 trade‐offs	 (Figure	3)	across	 the	 life	
span.	Ultimate	explanations	have	been	framed	around	four	aspects:	
quantitative	 sex	 differences	 in	 immune	 responses	 (a);	 qualitative	
sex	 differences	 in	 immune	 responses	 (b);	modified	 by	 transfer	 of	
immunity	between	generations	for	species	where	this	occurs	(c);	or	
modified	by	pregnancy,	for	relevant	species	(d).	Each	of	these	four	
framings	has	different	implications	for	the	evolution	of	sex	differ-
ences	in	senescence	(Table	1).	Empirical	studies	are	sorely	needed	
to	test	each	of	these	ideas.
The	 first	 framing	 broadly	 posits	 that	 the	 ‘caring’	 sex	 (females	
in	 many	 species)	 has	 been	 selected	 to	 have	more	 ‘robust’	 immune	
responses	 (Rolff,	 2002;	 Sheldon	 &	 Verhulst,	 1996;	 Zuk,	 2009).	
Empirically,	this	aligns	with	higher	antibody	titres	following	infection	
or	vaccination,	greater	macrophage	activity	(Klein	&	Flanagan,	2016),	
or	higher	immunopathology	in	females	from	influenza	even	at	equiva-
lent	viral	titres	(Robinson,	Lorenzo,	Jian,	&	Klein,	2011).	In	vertebrates,	
the	‘immunocompetence—handicap	hypothesis’	more	specifically	pos-
tulates	that	androgens	shunt	energy	away	from	the	immune	system	
towards	secondary	sexual	characteristics,	so	that	males	have	less	ro-
bust	immune	function	than	females,	and	thus,	only	high‐quality	males	
can	afford	displays	(Folstad	&	Karter,	1992).	Various	lines	of	evidence	
suggest	that	the	effects	of	testosterone	may	be	more	 immunomod-
ulatory	than	immunosuppressive	(e.g.	(Hodges‐Simeon,	Asif,	Gurven,	
Blackwell,	 &	 Gaulin,	 2019)),	 and	 overall,	 sex	 differences	 are	 more	
complex	 than	a	simple	 reduction	of	 immune	response	magnitude	 in	
the	non‐caring	sex	(Klein	&	Flanagan,	2016).	However,	assuming	that	
this	framing	provides	a	reasonable	approximation,	what	is	implied	for	
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immune‐mediated	effects	on	senescence?	The	sex	with	the	more	‘ro-
bust’	 immune	 response	might	be	expected	 to	suffer	more	 from	the	
negative	effects	of	potent	 immune	 responses	 (e.g.	 inflammaging)	 at	
late	ages,	but	less	from	infectious	disease.	Indeed,	the	concentration	
of	immunopathology‐associated	proteins	(IL‐6,	TNF‐alpha,	C‐reactive	
protein)	at	late	ages	is	generally	higher	in	females	(Bupp	et	al.,	2018).	
Some	evidence	also	supports	lower	infectious	disease	mortality	at	late	
ages	among	female	mammals	(Simon	et	al.,	2015),	although	the	causes	
of	death	in	natural	populations	are	often	unknown.
The	second	framing	emerges	from	accounting	for	qualitative	fea-
tures	of	immune	differences	(rather	than	a	quantitative	scale	of	‘more’	
vs.	‘less’	immune).	Females	may	have	been	selected	for	a	less	inflam-
matory	immune	response,	biased	instead	towards	T‐helper	type	2	im-
mune	responses	(thought	to	favour	pregnancy;	e.g.	in	natural	fertility	
human	populations;	(Blackwell	et	al.,	2015)),	while	males	are	selected	
for	 inflammatory	 responses	 as	 being	 swift	 although	 destructive,	 in	
line	with	males	being	selected	for	a	‘faster’	lifestyle	(Sears,	Rohr,	Allen,	
&	Martin,	2011);	see	also	(Roved,	Westerdahl,	&	Hasselquist,	2017).	
This	 framing	 broadly	 suggests	 opposite	 sex‐specific	 pathologies	 at	
late	ages	to	the	first	framing	(Table	1).	Qualitative	immune	differences	
can	also	be	framed	in	terms	of	trade‐offs	associated	with	pathogen	
discrimination	 and	 response	magnitude	 (Metcalf	 &	 Graham,	 2018).	
Empirically,	 in	 birds	 and	 mammals,	 enhanced	 pathogen detection is 
suggested	for	females,	where	the	magnitude of response is enhanced in 
males.	The	‘discriminating	females	versus	responding	males’	hypoth-
esis	 (Metcalf	&	Graham,	2018)	suggests	 females	may	deplete	pools	
of	naive	B	and	T	cells	faster,	potentially	leaving	them	more	vulnera-
ble	 to	 infection	at	 late	ages	 (suggested	at	 least	 for	 influenza	 (Kadel	
&	Kovats,	2018))	and	potentially	also	with	greater	immunopathology.	
While	measures	that	align	with	‘robust’	immunity	in	females	seem	to	
contradict	this	(e.g.	higher	immunopathology	in	infected	females),	this	
may	in	part	result	from	taking	static	measures	from	what	is	inherently	
a	dynamic	 system—if	pathogen	 incidence	 is	 low	 in	 females	 as	 a	 re-
sult	of	early	detection	and	exclusion	(e.g.	influenza	in	humans	(Kadel	
&	Kovats,	2018)),	 then	on	the	rare	occasions	 that	 the	pathogen	es-
capes	the	female	 immune	system's	vigilance,	pathogen	growth	may	
be	greater,	and	immunopathology	likewise	higher.
Third,	an	important	feature	of	immunity	is	the	potential	for	transfers	
between	generations	via	maternal	 (Boulinier	&	Staszewski,	2008)	or	
paternal	immunity	(Olivia	Roth	et	al.,	2010;	Roth,	Klein,	Beemelmanns,	
Scharsack,	&	Reusch,	2012).	The	sex	responsible	for	transferring	an-
tibodies	might	be	predicted	to	have	a	‘more	robust’	(Zuk,	2009),	less	
inflammatory	 (Sears	 et	 al.,	 2011)	 or	more	 discriminating	 (Metcalf	 &	
Graham,	 2018)	 immune	 system.	 In	 each	 scenario,	 the	 presence	 of	
TA B L E  1  Four	explanations	for	sex	differences	in	immunity	(columns,	see	text)	framed	in	terms	of	expectations	in	the	‘caring’	sex	
(generally	females),	and	expected	alignment	with	immune	trade‐offs	(rows)	with	implications	for	senescence	(final	row)
Trade‐off Quantitative differences Qualitative differences
Effect of transfer of 
antibodies Effect of pregnancy
Having an immune 
systema
More	expenditure Either Either Either
Maintaining an immune 
systema
More	expenditure Either Either Either
Discriminating to trigger a 
response	or	not	(favour-
ing	false	positives	vs.	
false	negatives)
Possibly	more	triggering	
(more	‘sensitive’,	Figure	
3a)
Undefined	(for	Th1/Th2	
contrast),	or	less	trigger-
ing,	that	is	less	sensitive	
(for	discrimination	
contrast)
More	trigger	(more	
sensitive)
Either
Magnitude	of	the	trig-
gered	responsea
Larger	response Smaller	inflammatory	
response	(for	Th1/Th2	
contrast)	and	immune	
effector	response	(for	
discrimination	contrast)
Either	(but	likely	smaller) Larger	response	to	
offset	females	spend-
ing	time	immunosup-
pressed	to	tolerate	a	
foetus
Tolerating	the	infection	
(without	reducing	bur-
den)	versus	nota
Possibly	greater	toler-
ance	to	offset	greater	
responses?
Greater	tolerance	(under	
Th1	vs.	Th2	contrast)	or	
either	(discrimination	
contrast)
Either Either
Resistance, that is	exclud-
ing	infectiona
Larger	investment Either Either Either
Implications for immune 
effects on survival in the 
caring sex at late ages
Greater	immunopathology	
and immune memory de-
pletion;	greater	survival	
in	the	face	of	late	life	in-
fections,	unless	memory	
depletion	has	reached	
problematic	levels
Less	(for	Th1/Th2	
contrast)	or	more	(for	
discrimination	contrast)	
immunopathology;	and	
less memory so less de-
fence	against	infection	
for	the	discrimination	
contrast
More	autoimmunity,	
immunopathology
More	autoimmunity,	
more	immunopathol-
ogy;	assuming	that	
change	is	in	magnitude	
rather	than	regulation
avs.	expending	resources	on	another	aspect	of	life	history	(survival,	fertility).	
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transfers	would	be	expected	to	provide	another	selection	pressure	to	
maintain	immune	function	in	the	face	of	senescence	for	as	long	as	off-
spring	were	being	produced	in	the	transferring	sex	and	thus	might	lead	
to	modify	patterns	of	senescence	between	the	sexes	(Table	1).
Fourth,	 pregnancy	 importantly	 defines	 female	 immune	 system	
function	 in	 mammals.	 During	 pregnancy,	 females	 must	 meet	 the	
physiological	challenge	of	not	responding	to	the	(non‐self)	foetus	to	
prevent	abortion,	driving	selection	for	greater	plasticity	(as	females	
move	 in	and	out	of	pregnancy)	 than	required	by	the	male	 immune	
system	(Natri,	Garcia,	Buetow,	Trumble,	&	Wilson,	2019),	a	process	
governed	 by	 hormones	 (Box	 1).	 Inferring	 how	 this	 will	 affect	 se-
nescence	is	not	straightforward,	in	part	because	some	of	the	most	
detailed	data	come	from	humans—yet	human	rates	of	pregnancy	in	
many	populations	are	currently	much	reduced	currently	relative	to	
what	might	have	been	the	case	historically	(Natri	et	al.,	2019)—and	
because	menopause	profoundly	alters	human	hormone	 levels,	and	
thereby	late	age	immune	function,	but	is	extremely	rare	across	the	
vertebrate	tree	of	life	(otherwise	only	found	in	a	few	cetacean	spe-
cies	(Whitehead,	2015)).	Beyond	the	fascinating	but	rare	example	of	
menopause,	 tight	dependence	of	 immune	 function	on	 female	hor-
mones	could	result	in	mutually	exclusive	scenarios	at	late	ages:	net-
works	that	are	robust	to	perturbations,	including	declines	occurring	
over	 senescence,	or	 sensitive	networks,	 leading	 to	 accelerated	 in-
flammaging	in	females.	Emergent	sex	differences	in	senescence	have	
the	potential	to	importantly	illuminate	the	links	between	immunity	
and	senescence.	Identifying	empirical	measures	to	discriminate	be-
tween	such	predictions	is	a	key	future	direction,	urgently	requiring	
associated	longitudinal	data	(Peters	et	al.,	2019).
7  | FUTURE DIREC TIONS
Immune	function	is	unique:	its	dangerous	side	(from	inflammation	
to	autoimmunity)	requires	careful	regulation,	while	its	role	in	path-
ogen	defence	calls	for	swift	reaction	and	a	capacity	for	memory.	
The	interdependent	system	that	has	evolved	to	meet	these	needs	
means	that	immune	changes	at	one	age	have	intricate	implications	
for	the	pattern	of	immune	function	both	concurrently	and	at	later	
ages.	This	complexity	makes	it	hard	to	determine	how	declining	se-
lection	pressures	with	age	have	altered	immune	function	in	ways	
that	modify	 senescence.	 Sex	 differences	 provide	 one	 avenue	 to	
probing	this	question—differing	selection	pressures	on	the	sexes	
will	 shape	differences	 in	 immune	 function	 that	 are	nevertheless	
occurring	within	the	same	bauplan.	While	we	have	laid	out	some	
broad	expectations	under	existing	theories	for	ultimate	drivers	of	
sex	differences	in	immunity	(Table	1,	last	row),	they	remain	neces-
sarily	vague,	given	issues	in	interpreting	what	the	various	models	
imply.	 Effectively	 leveraging	 the	 distinction	 between	 the	 sexes	
will	require	careful	theoretical	framing	of	the	various	ultimate	ex-
planations	and	extensive	empirical	study.	Measuring	outcomes	in	
terms	of	causes	of	death	has	 the	merit	of	being	 tractable,	but	 is	
also	comparable	across	models	(e.g.	whatever	the	nuance	of	detail	
in	immune	system	function	incorporated	within	models).
Developing	 the	 relevant	 theory	will	 clearly	 not	 be	 straightfor-
ward.	One	important	challenge	will	be	in	establishing	how	resource	
costs	are	paid	(Schwenke,	Lazzaro,	&	Wolfner,	2016),	 including	the	
issue	 of	 defining	 the	 shape	 of	 trade‐offs	 between	 investment	 in	
immune	 system	 maintenance/activation/etc	 versus	 investment	 in	
survival	 and	 fertility	 (likely	 themselves	 sex‐specific),	 as	well	 as	 re-
source	allocation	between	immune	functions.	Another	challenge	will	
be	reflecting	the	dynamical	aspects	of	immune	function	(Figure	2).	
While	generic	models	contrasting	these	broad	framings	may	not	lend	
themselves	to	teasing	apart	nuances	(e.g.	resources	playing	different	
roles	for	the	two	sexes	(Rapkin	et	al.,	2018)),	predictions	about	im-
mune	differences	between	males	and	females	at	different	ages	(e.g.	
at	differing	 resource	availability,	or	 for	species	with	very	different	
life	spans,	or	under	different	frequencies	of	pathogen	return)	could	
launch	quantitative	 tests	 of	 the	 explanatory	 power	 of	 the	 various	
models.
The	paucity	of	data	at	this	stage	means	that	we	are	in	little	dan-
ger	of	‘hypothesizing	after	the	results	are	known’,	but	empirical	mea-
sures	will	be	key	to	advancing	understanding.	Novel	tools	(e.g.	from	
CRISPR/CAS9	 knockouts	 to	 novel	 immune	measures)	with	 unique	
model	 systems	 that	 encompass	 an	 array	 of	 life	 histories	 (e.g.	 the	
Syngnathiformes	system	ranging	from	no	parental	care	to	paternal	
pregnancy),	and	a	more	comprehensive	array	of	hormones	that	af-
fect	 immunity	 (beyond	androgens),	will	also	contribute	 insight	 into	
patterns	 of	 immune	 function	 across	 the	 life	 course,	 and	 between	
the	 sexes.	 Detailing	 drivers	 of	 these	 patterns	 between	 the	 sexes	
will	allow	us	to	further	refine	our	understanding	of	core	trade‐offs	
across	the	life	span.
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